L. De Bock

发表

In Vitro Cytochrome P450 Activity Decreases in Children with High Pediatric End-Stage Liver Disease Scores

K. Boussery, M. Van Winckel, E. Sokal, 2013, Drug Metabolism and Disposition.

J. Remon, D. Deforce, K. Boussery, 2013, Journal of agricultural and food chemistry.

Quantification of cytochrome 2E1 in human liver microsomes using a validated indirect ELISA.

K. Boussery, P. Colin, J. Van Bocxlaer, 2014, Journal of pharmaceutical and biomedical analysis.

Development and validation of an enzyme-linked immunosorbent assay for the quantification of cytochrome 3A4 in human liver microsomes.

K. Boussery, P. Colin, J. Van Bocxlaer, 2012, Talanta.

Strategies for Determining Correct Cytochrome P450 Contributions in Hepatic Clearance Predictions: In Vitro–In Vivo Extrapolation as Modelling Approach and Tramadol as Proof-of Concept Compound

K. Boussery, K. Allegaert, P. Annaert, 2017, European Journal of Drug Metabolism and Pharmacokinetics.

Enzymatic tumour tissue digestion coupled to SPE-UPLC-Tandem Mass Spectrometry as a tool to explore paclitaxel tumour penetration.

C. Vervaet, K. Boussery, P. Colin, 2014, Talanta.

Development and validation of a fast and uniform approach to quantify β-lactam antibiotics in human plasma by solid phase extraction-liquid chromatography-electrospray-tandem mass spectrometry.

K. Boussery, P. Colin, J. Van Bocxlaer, 2013, Talanta.

Toxic effects of dietary exposure to T-2 toxin on intestinal and hepatic biotransformation enzymes and drug transporter systems in broiler chickens.

K. Boussery, V. Vandenbroucke, J. Goossens, 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Hepatic and intestinal CYP3A expression and activity in broilers.

K. Boussery, P. de Backer, S. Croubels, 2013, Journal of veterinary pharmacology and therapeutics.

K. Boussery, C. Casteleyn, S. V. Van Cruchten, 2015, Basic & clinical pharmacology & toxicology.

The Ontogeny of Cytochrome P450 Enzyme Activity and Protein Abundance in Conventional Pigs in Support of Preclinical Pediatric Drug Research

D. Deforce, E. Govaert, S. Croubels, 2018, Front. Pharmacol..

The mycotoxin T-2 inhibits hepatic cytochrome P4503A activity in pigs.

K. Boussery, E. Verbrugghe, J. Goossens, 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

Development and validation of a fast and sensitive UPLC-MS/MS method for the quantification of six probe metabolites for the in vitro determination of cytochrome P450 activity.

K. Boussery, P. Colin, J. Van Bocxlaer, 2012, Talanta.

The Introduction of a Full Medication Review Process in a Local Hospital: Successes and Barriers of a Pilot Project in the Geriatric Ward

K. Boussery, E. Tommelein, A. Somers, 2018, Pharmacy.

K. Boussery, C. Casteleyn, S. V. Van Cruchten, 2015, Basic & clinical pharmacology & toxicology.

Strategies for Determining Correct Cytochrome P450 Contributions in Hepatic Clearance Predictions: In Vitro–In Vivo Extrapolation as Modelling Approach and Tramadol as Proof-of Concept Compound

K. Boussery, K. Allegaert, P. Annaert, 2016, European Journal of Drug Metabolism and Pharmacokinetics.

In Vitro Cytochrome P450 Activity Decreases in Children with High Pediatric End-Stage Liver Disease Scores

K. Boussery, M. Van Winckel, E. Sokal, 2013, Drug Metabolism and Disposition.